Pralsetinib, CAS [[2097132-94-8]]

Produktübersicht

• Artikelname: Pralsetinib, CAS [[2097132-94-8]]
• Artikelnummer: BYT-ORB1296082
• Hersteller Artikelnummer: orb1296082
• Alternativnummer: BYT-ORB1296082-1, BYT-ORB1296082-1, BYT-ORB1296082-10, BYT-ORB1296082-100, BYT-ORB1296082-25, BYT-ORB1296082-5, BYT-ORB1296082-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Inhibitor, inhibit, cRET, Blu667, BLU-667, BLU 667, Pralsetinib, RET

Produktbeschreibung

Pralsetinib (BLU-667) is a potent and selective RET kinase inhibitor effective against wild-type RET, multiple mutants (V804L, V804M, M918T), and the CCDC6-RET fusion. It is a valuable research tool for investigating RET-driven pathologies, with demonstrated activity in both cellular assays and in vivo models of RET-altered cancers.

Produkteigenschaften

• Molekulargewicht: 533.6
• Reinheit: 99.80% (May vary between batches)
• CAS Nummer: [2097132-94-8]
• Formel: C27H32FN9O2
• Target-Kategorie: c-RET

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.18 mM),DMSO:126.25 mg/mL (236.6 mM)